logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Maxwell, James
    Born in December 1984
    Individual (17 offsprings)
    Officer
    icon of calendar 2024-02-15 ~ now
    OF - Director → CIF 0
  • 2
    Silver, Gabrielle Alison
    Born in September 1973
    Individual (19 offsprings)
    Officer
    icon of calendar 2024-02-15 ~ now
    OF - Director → CIF 0
  • 3
    AZIMUTH MEDICAL LIMITED - 2012-01-23
    icon of addressSuite A, Greenway House, Larkwood Way, Tytherington Business Park, Macclesfield, United Kingdom
    Active Corporate (3 parents, 2 offsprings)
    Equity (Company account)
    456,167 GBP2024-09-30
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 8
  • 1
    Smith, Edward James
    Individual
    Officer
    icon of calendar 2005-03-12 ~ 2012-06-07
    OF - Secretary → CIF 0
  • 2
    Smith, Graeme David
    Pharmaceutical Consulting born in February 1964
    Individual
    Officer
    icon of calendar 2005-03-12 ~ 2022-09-01
    OF - Director → CIF 0
  • 3
    Medley, Andrew John
    Director born in December 1967
    Individual (4 offsprings)
    Officer
    icon of calendar 2021-07-13 ~ 2024-04-19
    OF - Director → CIF 0
  • 4
    Bennett, Stephen William
    Individual (3 offsprings)
    Officer
    icon of calendar 2012-06-07 ~ 2021-07-13
    OF - Secretary → CIF 0
  • 5
    Chaffer, Daniel
    Director born in August 1977
    Individual (6 offsprings)
    Officer
    icon of calendar 2021-07-13 ~ 2023-07-14
    OF - Director → CIF 0
  • 6
    Stanton, Matthew James
    Pharmaceutical Consulting born in August 1967
    Individual (4 offsprings)
    Officer
    icon of calendar 2012-06-07 ~ 2019-11-07
    OF - Director → CIF 0
  • 7
    FOCUSOPTION LIMITED - 1996-12-02
    icon of addressRegent House, 316 Beulah Hill, London
    Active Corporate (3 parents, 8 offsprings)
    Equity (Company account)
    2 GBP2024-09-30
    Officer
    2005-03-12 ~ 2005-03-12
    PE - Nominee Director → CIF 0
  • 8
    M.W. DOUGLAS & COMPANY LIMITED
    icon of addressRegent House, 316 Beulah Hill, London
    Active Corporate (2 parents, 33 offsprings)
    Equity (Company account)
    2 GBP2024-04-30
    Officer
    2005-03-12 ~ 2005-03-12
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

FORTIS PHARMA CONSULTING LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
212023-10-01 ~ 2024-09-30
232022-10-01 ~ 2023-09-30
Turnover/Revenue
3,409,128 GBP2023-10-01 ~ 2024-09-30
4,294,409 GBP2022-10-01 ~ 2023-09-30
Cost of Sales
-1,610,810 GBP2023-10-01 ~ 2024-09-30
-1,930,843 GBP2022-10-01 ~ 2023-09-30
Gross Profit/Loss
1,798,318 GBP2023-10-01 ~ 2024-09-30
2,363,566 GBP2022-10-01 ~ 2023-09-30
Administrative Expenses
-186,470 GBP2023-10-01 ~ 2024-09-30
-242,722 GBP2022-10-01 ~ 2023-09-30
Operating Profit/Loss
1,756,194 GBP2023-10-01 ~ 2024-09-30
2,120,844 GBP2022-10-01 ~ 2023-09-30
Other Interest Receivable/Similar Income (Finance Income)
4 GBP2023-10-01 ~ 2024-09-30
166 GBP2022-10-01 ~ 2023-09-30
Interest Payable/Similar Charges (Finance Costs)
-3,192 GBP2023-10-01 ~ 2024-09-30
Profit/Loss on Ordinary Activities Before Tax
1,753,006 GBP2023-10-01 ~ 2024-09-30
2,121,010 GBP2022-10-01 ~ 2023-09-30
Equity
Retained earnings (accumulated losses)
7,271,262 GBP2024-09-30
5,547,773 GBP2023-09-30
3,425,781 GBP2022-10-01
Profit/Loss
Retained earnings (accumulated losses)
1,723,489 GBP2023-10-01 ~ 2024-09-30
2,121,992 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
4,577 GBP2023-09-30
Fixed Assets
4,577 GBP2023-09-30
Debtors
Current
7,384,489 GBP2024-09-30
5,624,517 GBP2023-09-30
Cash at bank and in hand
516,994 GBP2024-09-30
373,061 GBP2023-09-30
Current Assets
7,901,483 GBP2024-09-30
5,997,578 GBP2023-09-30
Creditors
Current, Amounts falling due within one year
-454,380 GBP2023-09-30
Net Current Assets/Liabilities
7,271,264 GBP2024-09-30
5,543,198 GBP2023-09-30
Total Assets Less Current Liabilities
7,271,264 GBP2024-09-30
5,547,775 GBP2023-09-30
Net Assets/Liabilities
7,271,264 GBP2024-09-30
5,547,775 GBP2023-09-30
Equity
Called up share capital
2 GBP2024-09-30
2 GBP2023-09-30
Equity
7,271,264 GBP2024-09-30
5,547,775 GBP2023-09-30
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
332023-10-01 ~ 2024-09-30
Computers
332023-10-01 ~ 2024-09-30
Wages/Salaries
1,019,544 GBP2023-10-01 ~ 2024-09-30
1,169,722 GBP2022-10-01 ~ 2023-09-30
Social Security Costs
122,501 GBP2023-10-01 ~ 2024-09-30
137,419 GBP2022-10-01 ~ 2023-09-30
Staff Costs/Employee Benefits Expense
1,191,737 GBP2023-10-01 ~ 2024-09-30
1,359,625 GBP2022-10-01 ~ 2023-09-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-1,098 GBP2023-10-01 ~ 2024-09-30
-982 GBP2022-10-01 ~ 2023-09-30
Tax Expense/Credit at Applicable Tax Rate
438,252 GBP2023-10-01 ~ 2024-09-30
530,253 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
6,346 GBP2023-09-30
Computers
18,644 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
24,990 GBP2023-09-30
Property, Plant & Equipment - Other Disposals
Plant and equipment
-6,346 GBP2023-10-01 ~ 2024-09-30
Computers
-18,644 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Other Disposals
-24,990 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
5,453 GBP2023-09-30
Computers
14,960 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
20,413 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
864 GBP2023-10-01 ~ 2024-09-30
Owned/Freehold
3,113 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-6,317 GBP2023-10-01 ~ 2024-09-30
Computers
-17,209 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-23,526 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment
Plant and equipment
893 GBP2023-09-30
Computers
3,684 GBP2023-09-30
Trade Debtors/Trade Receivables
Current
591,964 GBP2024-09-30
687,622 GBP2023-09-30
Amounts Owed by Group Undertakings
Current
6,321,348 GBP2024-09-30
4,624,210 GBP2023-09-30
Prepayments/Accrued Income
Current
355,721 GBP2024-09-30
312,058 GBP2023-09-30
Other Debtors
Current
113,731 GBP2024-09-30
Debtors - Deferred Tax Asset
Current
1,725 GBP2024-09-30
627 GBP2023-09-30
Trade Creditors/Trade Payables
Current
7,839 GBP2024-09-30
21,205 GBP2023-09-30
Amounts owed to group undertakings
Current
108,349 GBP2024-09-30
11,073 GBP2023-09-30
Taxation/Social Security Payable
Current
26,703 GBP2024-09-30
28,194 GBP2023-09-30
Other Creditors
Current
6,945 GBP2024-09-30
28,515 GBP2023-09-30
Accrued Liabilities/Deferred Income
Current
480,383 GBP2024-09-30
365,393 GBP2023-09-30
Creditors
Current
630,219 GBP2024-09-30
454,380 GBP2023-09-30
Net Deferred Tax Liability/Asset
1,725 GBP2024-09-30
627 GBP2023-09-30
-355 GBP2022-10-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
1,098 GBP2023-10-01 ~ 2024-09-30
982 GBP2022-10-01 ~ 2023-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2024-09-30
2 shares2023-09-30
Par Value of Share
Class 1 ordinary share
1.002023-10-01 ~ 2024-09-30
Related profiles found in government register
  • FORTIS PHARMA CONSULTING LIMITED
    Info
    Registered number 05390470
    icon of addressSuite A, Greenway House Larkwood Way, Tytherington Business Park, Macclesfield SK10 2XR
    PRIVATE LIMITED COMPANY incorporated on 2005-03-12 (20 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-23
    CIF 0
  • FORTIS PHARMA CONSULTING LTD
    S
    Registered number 05390470
    icon of addressRopewalks, Newton Street, Macclesfield, England, SK11 6QJ
    Limited Company in Registrar Of Companies - England & Wales, England
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of addressRopewalks, Newton St, Macclesfield, United Kingdom
    Dissolved Corporate (2 parents)
    Equity (Company account)
    10 GBP2022-09-30
    Person with significant control
    icon of calendar 2016-04-06 ~ dissolved
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.